Related Experiment Video
Updated: May 9, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Structural determinants regulating cell surface targeting of melanocortin receptors
A R Rodrigues1, D Sousa, H Almeida
1Department of Experimental Biology, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal Instituto de Biologia Molecular e Celular (IBMC), University of Porto, Porto, Portugal IPATIMUP, Institute of Molecular Pathology and Immunology Faculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal.
Melanocortin receptors (MCRs) require specific structural motifs and accessory proteins for proper cell surface expression. Pharmacological stabilization of mutant MCRs offers a promising therapeutic approach for related diseases.
Area of Science:
- Molecular biology
- Cell biology
- Pharmacology
Background:
- Melanocortin receptors (MCRs) are G-protein-coupled receptors crucial for cellular signaling.
- MCRs recognize melanocortin ligands synthesized in the pituitary and hypothalamus.
- Proper cell surface expression of MCRs depends on quality control mechanisms during synthesis.
Purpose of the Study:
- To review structural determinants involved in MCRs' cell surface targeting.
- To explore the role of accessory proteins and post-translational modifications in MCR trafficking.
- To discuss pharmacological strategies for correcting MCR misfolding and misrouting.
Main Methods:
- Literature review of studies on MCR structure, function, and trafficking.
- Analysis of domains and motifs critical for MCR processing and cell surface expression.
- Examination of accessory proteins and post-translational modifications influencing MCRs.
- Review of therapeutic approaches targeting MCRs.
Main Results:
- Specific motifs in MCRs (N/C-terminus, transmembrane, loop regions) are vital for quality control.
- Accessory proteins and post-translational modifications significantly impact MCR cell surface targeting.
- Pharmacological stabilization can correct misfolded/misrouted mutant MCRs, enhancing forward transport.
Conclusions:
- Understanding MCR structural determinants is key to addressing diseases linked to MCR dysfunction.
- Targeting MCR trafficking pathways offers potential therapeutic benefits.
- Pharmacological interventions show promise for treating MCR-related disorders.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Types of Receptors: Cell Surface Receptors
Regulation of Nuclear Protein Sorting
Receptor-mediated Endocytosis
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

